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Abstract
Background: The discovery of RNA interference phenomenon (RNAi) and understanding of its mechanisms has
revolutionized our views on many molecular processes in the living cell. Among the other, RNAi is involved in
silencing of transposable elements and in inhibition of virus infection in various eukaryotic organisms. Recent
experimental studies demonstrate few cases of viral replication suppression via complementary interactions
between the mammalian small RNAs and viral transcripts.
Presentation of the hypothesis: It was found that >50% of the human genome is transcribed in different cell
types and that these transcripts are mainly not associated with known protein coding genes, but represent non-
coding RNAs of unknown functions. We propose a hypothesis that mammalian DNAs encode thousands RNA
motifs that may serve for antiviral protection. We also presume that the evolutional success of some groups of
genomic repeats and, in particular, of transposable elements (TEs) may be due to their ability to provide antiviral
RNA motifs to the host organism. Intense genomic repeat propagation into the genome would inevitably cause
bidirectional transcription of these sequences, and the resulting double-stranded RNAs may be recognized and
processed by the RNA interference enzymatic machinery. Provided that these processed target motifs may be
complementary to viral transcripts, fixation of the repeats into the host genome may be of a considerable benefit
to the host. It fits with our bioinformatical data revealing thousands of 21-28 bp long motifs identical between
human DNA and human-pathogenic adenoviral and herpesviral genomes. Many of these motifs are transcribed in
human cells, and the transcribed part grows proportionally to their lengths. Many such motifs are included in
human TEs. For example, one 23 nt-long motif that is a part of human abundant Alu retrotransposon, shares
sequence identity with eight human adenoviral genomes.
Testing the hypothesis: This hypothesis could be tested on various mammalian species and viruses infecting
mammalian cells.
Implications of the hypothesis: This hypothesis proposes that mammalian organisms may use their own
genomes as sources of thousands of putative interfering RNA motifs that can be recruited to repress intracellular
pathogens like proliferating viruses.
Reviewers: This article was reviewed by Eugene V. Koonin, Valerian V. Dolja and Yuri V. Shpakovski.
Background
The discovery of RNA interference (RNAi) and under-
standing of its mechanisms has opened a new era in
molecular genetics. It is now clear that very small com-
plementary RNAs may modulate expression of large
genes. RNAi and related mechanisms may interfere with
gene expression at the stages of transcription, processing
of mRNA and translation [1,2]. They may alter tran-
script stability and may even cause methylation of
extended genomic loci [3,4]. RNAi is a very conservative
mechanism that is likely to be active in almost all eukar-
yotic taxa. This phenomenon attracts growing attention
and studying RNA interference is probably one of the
most rapidly developing fields of modern science.
Known RNAi pathways are very diverse [2] and many
new mechanisms are probably still to be discovered [5].
A fundamental step of RNAi is the basepairing of the
two interacting RNAs. The resulting duplexes, that may
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nized by the cellular RNAi machinery which may result
in silencing of the source gene for one of the above
interacting RNAs. The complementary motifs in RNA
may be only 21 nucleotides long or even smaller [6,7].
At present, RNAi is known to control genes involved in
all fields of cell functioning, including proliferation,
growth, differentiation and cell death [1,8,9]. There are
also some “exotic” functions like the control of genomic
transposable elements. Transposable elements (TEs) are
“selfish” fragments of genomic DNA able to self-repro-
duce and to insert into new locations into the host gen-
ome. TEs occupy huge space in eukaryotic DNA, e.g.
they account for at least 50% of the human genome [10]
and 50-90% of the genomes of many plant species [11].
Different TE families may be represented in genomes by
a very different number of representatives like tens,
hundreds, thousands, and even millions of TE copies
per genome. Although TE copies fixed in the genome
are most frequently neutral or even advantageous to the
host organism, their uncontrolled proliferation and
insertional activity may cause multiple genetic and
developmental deleterious effects [12-16].
At least in several species, TE proliferation is con-
trolled by the RNAi mechanisms [17,18]. For example,
in the DNA of fruitfly Drosophila melanogaster there
are several conserved loci that do not encode any func-
tional genes, but instead contain mutated copies of
some TEs [19]. These loci are transcribed in both sense
and antisense orientations, which results in generation
of large double-stranded RNAs (dsRNAs) including TE
sequences. Such dsRNAs are recognized by the cellular
RNAi machinery that further represses expression of all
genomic TEs identical to those located in the above
loci. When these loci are highly transcriptionally active,
protection against TE expression is strong, when they
are silent or hardly transcribed - the protection is weak
[20,21].
Presentation of the hypothesis
In the DNAs of some prokaryotes (e.g., E. coli), there are
~50 bp long sequence motifs identical to fragments of
bacteriophagal genomes. It was shown that the presence
of these motifs in the bacterial DNA protects them from
bacteriophagal infection, although the mechanism of this
protection (probably not RNAi) remains a mystery [22].
Also, it was recently hypothesized that there may be a
specific mechanism in crustaceans that provides reverse
transcription of viral transcripts and subsequent inser-
tion of the resulting cDNAs into the genome. Further
transcription of these cDNAs in the antisense orienta-
tion may help the host organisms to resist future viral
infections by acting as an intracellular specific immunity
system [23]. There is a growing number of instances of
acquisition of RNA virus sequences by eukaryotic gen-
omes that were proposed to function in antiviral defense
[24]. However, at present, the mechanism of the RNAi
based antiviral protection in eukaryotic organisms has
not been sufficiently investigated [25]. Theoretically,
RNAi could well serve as intracellular “immune system”
by repressing transcription of not only intra-genomic
parasites like TEs, but also of external ones like viruses.
In plants and in invertebrates, many cases of viral gene
suppression using small interfering RNAs originating
from viral double stranded RNAs have been documen-
ted to the date [26]. Furthermore, several examples of
virus-encoded small interfering RNAs that may regulate
host gene expression became available recently [27].
Finally, at least in the four cases mammalian siRNAs are
thought to interfere with viral transcripts, thus prevent-
ing efficient virus replication [28-31].
Eukaryotic genomes differ greatly in size
Genome sizes in eukaryotes may vary more than 50.000-
fold, from ~ 12 × 10
6 b pl i k ei nt h ec a s eo fy e a s t
Saccharomyces cerevisiae haploid genome [32], and up
to over 670 × 10
9 bp, like for protist Amoeba dubia
[33]. In vertebrate organisms, sizes differ from ~ 380 ×
10
6 bp (puffer fish Tetraodon nigroviridis) to ~130 × 10
9
bp (marbled lungfish Protopterus aethiopicus)w i t ht h e
intermediate value of ~3 × 10
9 for human haploid gen-
ome [33].
T h eg e n o m eg r o w t ho c c u r sb yv i r t u eo fv a r i o u sp r o -
cesses the most important of which are random DNA
duplication and propagation of transposable elements
[34,35]. In the large eukaryotic DNAs, protein coding
sequences occupy a rather modest fraction (a few per-
cent or lower), whereas significantly bigger parts of
these genomes appear to be transcribed. For example,
according to the published data, more than 50% of the
human DNA is transcribed in different cell types [36].
These transcripts are frequently not associated with any
known genes, but represent non-coding RNAs of
unknown functions [37]. At least part of these tran-
scripts is likely to participate in RNAi-mediated regula-
tion of gene expression.
The hypothesis
We propose a hypothesis that virus suppression
mediated by self-encoded small interfering RNAs is not
an exception but is rather a general case for the mam-
malian genomes and, probably, for other relatively big
eukaryotic genomes. These genomes may include rela-
tively short motifs sharing high sequence identity with
viral genes, and, when transcribed, these motifs may
function for the antiviral host cell defense. In this light
the enlargement of genome sizes may be beneficial to
the host organisms as a source of novel putative
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intracellular pathogens like proliferating viruses. An
increased genome would allow an “empty space” for the
evolution of different genetic elements, including non-
coding DNA. Casual combinations of nucleotides in the
new part of the genome might create new DNA motifs
that theoretically, after being transcribed, could be used
by the host organism as a tool for recognition and tar-
geting of intracellular pathogen transcripts. Novel tran-
scribed DNA motifs that would target the host genes
would be eliminated from the genome, whereas those
that complementarily match with the pathogen RNAs
would be positively selected. Neutral motifs could be
“stored” in the genomes as ordinary non-coding DNA.
Mechanisms of genome size increase might include
DNA duplications, expansion of satellite sequences,
emergence of polyploid chromosomes, and insertions of
transposable elements [38]. Initially, the newly amplified
part of the genome is identical or very close to the “pro-
genitor” genomic DNA. However, neutral or non-neutral
mutation pressure may form a novel DNA landscape
within the amplified fragments during genome evolu-
tion. In case of being transcribed, these loci might sig-
nificantly increase the repertoire of cellular interfering
RNAs.
We also presume that the evolutional success of some
groups of genomic repeats and, in particular, transposa-
ble elements (TEs) at least partly may be due to their
ability to provide antiviral RNA motifs to the host
organism. Intense propagation of the repetitive elements
into the genome would necessarily cause bidirectional
transcription of these sequences, and the resulting dou-
ble-stranded RNAs may be recognized and processed by
the RNA interference enzymatic machinery. Provided
that these processed target motifs may be complemen-
tary to viral transcripts, fixation of the repeats into the
host genome may be of a considerable benefit to the
host.
We performed a bioinformatic assay aimed to quantify
in human DNA sequence motifs that perfectly match on
26 published adenoviral genomes (Figure 1). Human
adenoviral genomes have similar lengths of ~34-36 kb
and encode each for approximately 35 viral genes [39].
Only different nucleotide motifs were taken into
account, motifs repeated in human or adenoviral gen-
ome several times were considered as a sole motif. Each
motif was quantified only once, e.g. 25 nt-long sequence
was registered only as one 25 nt-long motif, but not
also as 24-, 23-, 22- and 21 nt-long motifs.
For different human adenoviruses, we identified 47-
106 perfectly matched 21 nt-long motifs, 16-44 22 nt-
long, 4-19 23 nt-long, 0-8 24 nt-long, 0-6 25 nt-long, 0-
6 26 nt-long and 0-1 27-, 28- and 29 nt-long motifs per
genome. The overall number of such motifs varied from
85 to 161. Provided that more than 50% of human DNA
is transcribed, and that this transcription may be driven
in both directions, we may expect that more than a
quarter of the above complementary motifs are tran-
scribed within the RNA molecules in the antisense
orientation relatively to adenoviral gene transcriptional
direction. At least theoretically these motifs might be
somehow involved in downregulation of viral genes.
Similar data were obtained when comparing human
DNA with 10 human pathogenic herpesvirus genomes.
We further compared relative occurrences of 21-29 nt
long hits among adenoviral, herpesviral and bacteriopha-
gal genomes (a list of the investigated viral genomes can
be found in Table 1). To this end, the number of the
respective identified BLAST hits was normalized to 1 kb
of each virus genome sequence. The resulting figure
clearly shows an approximately 3-fold greater average
number of hits for adenoviral and herpesviral genomes
rather than for bacteriophages in all size ranges (Figure
2). The excess of hits in human-pathogenic virus gen-
omes compared to bacteriophages was statistically
significant with p-values < 0,01 for 21-25 nt-long hits
(p-values shown on Table 1).
Alternatively, we compared human-virus sequence
identities using a panel of randomly generated genomes.
Using 2
nd -a n d5
th order Markov model we generated
random sequences by shuffling the actual adenoviral,
herpesviral and bacteriophagal genomes. Under this
approach, 1000 random sequences were generated sepa-
rately for each investigated viral genome. We next com-
pared numbers of BLAST hits for the existing viral
genomes, and for in silico generated ones. The observed
BLAST hits (total numbers of BLAST hits were found
for each genome) were statistically analyzed (Table 2),
and the following was found: (i) the number of hits for
the existing adenoviral or herpesviral genome was
mostly higher than the 95
th percentile for a set of the
corresponding in silico-generated sequences (in 81% or
89% of the cases, respectively, for 5
th order Markov
model), (ii) for the bacteriophages, this number was
mostly below the 95% percentile and expanded it only
in 38% of the cases). Again, these data confirm that
human-pathogenic viruses share significantly greater
structural identity with the human genome than do the
bacteriophagal genomes. Importantly, this also implies
that there was a kind of positive selection for either the
“virus-like” sequences in the human DNA, or for the
“humanized” DNA in the human-pathogenic viruses, or
both.
Our further studies revealed that many human-virus
BLAST hits appeared to be transcribed in human, as
learned from the analysis of human EST database (Fig-
ure 3). As before, numbers of transcribed hits for
herpes- and adenoviral genomes were far greater than
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dency towards a greater representation of longer herpes-
and adenoviral hits in the human EST database, com-
pared to the absence of relatively “long” transcribed hits
for the phages (Figure 3). In several cases the number of
“transcribed” hits was even higher than the number of
hits matching human genomic DNA database (adeno-
viral genomes, 26 nt-long motifs). Detailed analysis of
those sequences revealed that this was due to transcrip-
tional processing features such as splicing and
polyadenylation that increased variability of the tran-
scribed part of human genome.
Therefore, the results of this pilot assay point to accu-
mulation and functional relevance of the infectious-
virus-like sequences of the human genome.
Many such identical motifs were parts of human
transposable elements. For example, one 23 nt-long
motif (CGTACTTCAGCCTGGGCAACAAG)t h a ts h a r e d
perfect sequence identity with three adenoviral genomes
and considerable identities - with five other adenoviral
genomes, was included in a variant of human transposa-
ble element of AluS family and was represented in the
genome by multiple copies. We further investigated
whether consensus sequences of other human TE
families include sequence motifs perfectly matching to
human adenovirus or human herpesvirus genomes. We
were registering only the hits displaying perfectly
matched 16 nt- long or more extended motifs (Figure
4). Such hits have been found for 23 out of 51 human
TE families, and the distribution of hits there was not
uniform. The highest relativ en u m b e r so fi d e n t i t i e sp e r
1 kb of the TE consensus sequence were detected for
different subfamilies of human retrotransposon Alu,
which is known to be the most successful human TE in
terms of propagation of its copies (over 1 million of
copies per genome). Interestingly, it has been reported
previously that adenoviral infection results in a dramatic
increase in Alu transcription in human cells [40]. Our
hypothesis might at least partly explain this
phenomenon.
Figure 1 Human genome contains sequence motifs identical to the DNAs of human adenoviruses. Human adenovirus types are shown
on abscises axis. Histogram represents numbers of 21-, 22-, 23-, 24-, 25-, 26-, 27-, 28- and 29 nucleotide long sequence motifs identical between
human and adenoviral genomes. Complete human adenovirus genome sequences were extracted from GenBank. Quantization of perfectly
matching nucleotide motifs was done using the BLAST Web-server at NCBI [44].
Table 1 P-values calculated for the distribution of
perfectly matching human DNA 21-27 nt-long hits
between the different types of viral and randomly
generated genomes
Hits, nt-long
1 AV-Phage
2 HV-Phage
3 HV-AV
4
21 <0,0001 0,003 0,19
22 <0,0001 0,0017 0,016
23 <0,0001 0,0023 0,004
24 <0,0001 0,0019 0,94
25 0,0022 0,0032 0,99
26 0,013 0,0005 0,06
27 0,38 0,058 0,48
1 P-values were calculated using GraphPadPrism software. For 21-24 nt-long
hits, t-test for normal distribution was used; for 25-27 nt-long hits, non-
parametric Mann-Whitney test was used.
2P-values for the comparison of adenoviral and bacteriophagal hits.
3P-values for the comparison of herpesviral and bacteriophagal hits.
4P-values for the comparison of adenoviral and herpesviral hits.
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bacteriophagal genomes. Ordinate axis represents the average number of BLAST hits per 1 kb of virus genome sequence calculated for each
individual virus under investigation. Results for adenoviruses are shown in red, for herpes viruses - in green and for phages - in blue. Probability
density functions are shown for normal distribution model. Bars delineate, where applicable, percentiles for 5, 25, 50, 75 and 95% probabilities.
Empty boxes represent average values. Graphs were built using OriginPro 8 software.
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Virus
1 Accession number (NCBI PubMed) Original Genome
2 Markov 2
nd order,
percentile
3
Markov 5
th order,
percentile
3
5 50 95 5 50 95
av-01 [GenBank:AC_000017]
[GenBank:BK005234]
368 10 20 36,95 15 30 56
av-02 [GenBank:AC_000007] 1413 10 20 35 14,05 29 54,95
av-03 [GenBank:AY599834] 561 14 28 47 22 39 62,95
av-04 [GenBank:AY599837] 70 9,05 19 42,9 16 28 60,95
av-05 [GenBank:AC_000008] 92 9,05 20 37 14 28 63,95
av-06 [GenBank:FJ349096] 55 19 35 58 24,05 47 126,9
av-07 [GenBank:AC_000018] [GenBank:BK005235] 498 16 27 46,95 23,05 41 76,85
av-08 [GenBank:AB448769] 171 11 22 40 16 32 56
av-09 [GenBank:AJ854486] 113 8 18 28,95 14,05 26 50
av-10-02 [GenBank:AB023548] 821 9 2 14 31 83 26 4
av-10-03 [GenBank:AB330091] 55 23 47 68
av-10 [GenBank:DQ149615] 84 61 76 165,7 62 81 186,9
av-11 [GenBank:AC_000015] [GenBank:BK001453] 101 18 30 54,95 27,05 45 88,85
av-12 [GenBank:X73487] 132 24 42 68,9 33 52 80
av-13-02 [GenBank:DQ149616] 72 19,05 47 73,95
av-13 [GenBank:AB330094] 815 10 22 44,95 18 33 79,95
av-14 [GenBank:FJ822614] 63 18 31 53,95 25 42 72,9
av-15 [GenBank:DQ149617] 814 11,05 23 46,8 15 31 62
av-16 [GenBank:AY601636] 75 13,05 27 47,95 21 38 66
av-17 [GenBank:AF108105] 89 8 18,5 34,9 14 27 51
av-18 [GenBank:GU191019] 45 19 33 67,95 20 36 67,95
av-19 [GenBank:AB448774] 162 9,05 19 36 14 27 48
av-20 [GenBank:DQ149619] 813 12 25 49,95
av-21 [GenBank:AY601633] 53 25 41 61,95 26 46 80,95
av-22 [GenBank:FJ404771] 153 7 1 83 31 42 64 5
av-23 [GenBank:DQ149621] 801 10 22 41,95 14 29 63,8
av-24 [GenBank:DQ149622] 802 10,05 22 37 16 31 63,95
av-25 [GenBank:DQ149623] 808 11 22 45
av-26 [GenBank:EF153474] 119 8 18 36 14,05 27 58,95
av-27-02 [GenBank:DQ149625] 65 22,05 53 73
av-27 [GenBank:AB330108] 805 12 23 48,95 16 34 66,7
av-28 [GenBank:FJ824826] 151 8 18 34,95 13 25 45,95
av-29-02 [GenBank:DQ149627] 65 22 52 75,9
av-29 [GenBank:AB330110] 802 11 22 41,95 15 31 57,95
av-30 [GenBank:DQ149628] 809 9,05 23 48,95
av-31-02 [GenBank:AB330111] 63 63 75 105 64 78 199,6
av-31 [GenBank:DQ149611] 62 22 45 68,95 28 50,5 97,7
av-32 [GenBank:DQ149629] 833 10 23 41,95
av-33 [GenBank:DQ149630] 803 9,05 21 43,9 16 33 71,95
av-34 [GenBank:AY737797] 230 18 30 49 26 45 73,9
av-35 [GenBank:AC_000019] [GenBank:BK005236] 125 18 30 56,95 26,05 45 69
av-36 [GenBank:GQ384080] 804 9 23 46,95
av-37 [GenBank:AB448778] 123 8 19 39 14 27 51,9
av-38 [GenBank:DQ149633] 828 10,05 23 49,95
av-39 [GenBank:DQ149634] 814 11 22,5 45,85
av-40-f [GenBank:L19443] 319 13 27 56 19,05 33 65
av-41 [GenBank:HM565136] 4136 14 27 56,9 22 39 73,95
av-42 [GenBank:DQ149635] 814 11 24 43,9 20 37 82,95
av-43 [GenBank:DQ149636] 811 10,05 23 48,8
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genomes (Murine adenovirus A and Murid herpesvirus
1) against human and mouse genomic and EST data-
bases. For both mouse adenoviral and herpesviral gen-
omes, the number of 21-28 nt-long hits was higher
when searched through the mouse genomic and EST
databases compared to the human ones (Figure 5).
Among the identified virus-like hits presented in both
human and mouse DNAs, three sequences were simple
repeats represented by multiple copies in both genomes
(motifs TGCTGATGCTGATGCTGATGCTGATG, CATC-
CATCCATCCATCCATCC and ATTCTTTCATTCTTT-
CATTCTTT). Importantly, their copy numbers were very
different in the mouse and human DNAs (mouse/human):
1216/194, 20384/13893 and 1120/192, respectively. Thus,
a kind of positive selection for simple repetitive elements
matching genomes of the viruses with the respective trop-
ism may theoretically take place in this case.
Finally, in addition to antiviral adaptations the above
identities of the host and viral genomes may also repre-
sent a virus adjustment to the host aimed at the regula-
tion of the host gene expression that may facilitate viral
life cycle progression (reviewed in [27]). Both lines of
co-evolution are possible, and detailed experimental stu-
dies will be necessary to explore each case of the host-
virus sequence coincidence.
Testing the hypothesis
Objects
O b j e c t sf o rt e s t i n gt h i sh y p o t h e s i sc o u l db ev a r i o u s
mammalian species and viruses infecting mammalian
cells.
Table 2 BLAST hits found for the existing and randomly generated genomes (Continued)
av-44 [GenBank:DQ149637] 802 8 21 45,85
av-45 [GenBank:DQ149638] 821 10 23 45,9
av-46 [GenBank:AY875648] 114 8 18 34 14 26 49,95
av-47 [GenBank:DQ149640] 807 10,05 24 56
av-48-merged [GenBank:EF153473] 149 10 18 35,95 14 27 54
av-49-merged [GenBank:DQ393829] 217 8 18 32,95 16 28 59,95
av-50-merged [GenBank:AY737798] 83 12 28 47,9 21,05 38 59
av-51 [GenBank:DQ149642] 828 10,05 23,5 52,95
herp1 [GenBank:NC_001806] 2480 8 17 33 13 26,5 54
herp2 [GenBank:NC_001798] 79163 10 20 36 19 35 63
herp3 [GenBank:NC_001348] 23 41 70
herp4 type1 [GenBank:NC_007605] 1114 23 38 64 29,05 47 63
herp4 [GenBank:NC_009334] 516 25 39 58,95 29 47 69,95
herp5 [GenBank:NC_006273] 1215 8 16 34,95 17 33 78
herp6a [GenBank:NC_001664] 15330 56 68 99,9 68,05 118 2272
herp6b [GenBank:NC_000898] 15313 56 68 114 1653 6483 13459
herp7 [GenBank:NC_001716] 40093 85 108 217 84929 1E+05 1E+05
herp8 [GenBank:NC_009333] 2478 13 24 46,85 16 29 51
Bacillus phage BCJA1c [GenBank:NC_006557] 75 53 65 84 53,05 65 100,7
Burkholderia phage BcepNY3 [GenBank:NC_009604] 17 2 5 12,95 2 5 13
Clostridium phage phi CD119 [GenBank:NC_007917] 344 197 263 1028 194 247 454,5
Klebsiella phage KP32 [GenBank:NC_013647] 20 7 16 30 7 16 31,9
Listeria phage B025 [GenBank:NC_009812] 11268 84 105 173,8 83 106 171,8
Pseudomonas phage phi-2 [GenBank:NC_013638] 58 4,05 12 23,95 4 13 35,85
Staphylococcus phage 53 [GenBank:NC_007049] 119 76 95 150,8 76 93 135,9
Halomonas phage phiHAP-1 [GenBank:NC_010342] 21 3 9 21,95 2,05 9 22
Mycobacterium phage Cali [GenBank:NC_011271] 51 3,05 10 24 5 12 22
Pseudomonas phage DMS3 [GenBank:NC_008717] 12 4 10 26,95 4 10 24,9
Pseudomonas phage SN [GenBank:NC_011756] 27 9 19 33 9 20 38
Rhizobium phage 16-3 [GenBank:NC_011103] 14 4 12 25 5 13 26,95
Xylella phage Xfas53 [GenBank:NC_013599] 52 4 12 24 4 12 28,9
1Virus title. AV 01-51, adenoviral genomes (green). Herp 1-8, herpes virus genomes (yellow). The bacteriophagal genomes are shown in pink.
2The total number of BLAST hits found for the original viral genome. The default “Nucleotide BLAST” for the “BLAST at NCBI” search criteria were used.
3The data obtained for the sets of random genomes generated using Markov chain 2
nd -a n d5
th order algorithm. 1.000 random sequences were generated for
every existing viral genome. Expected numbers of BLAST hits for the 5
th,5 0
th and 95
th percentiles are given, accordingly. The data was generated using specially
designed script. The script “BioVictor-Python1” is available upon the request to the authors.
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Page 7 of 16Figure 3 Genomic and transcribed sequences identical between the human and viral genomes. Human adenoviral, human herpes viral
and bacteriophagal genomes were analyzed. Blue columns delineate BLAST hits found in human genomic DNA databases (non-redundant
sequences + HTGS), lilac - hits identified using human expressed sequence tag (EST) database. Ordinate axis represents average number of hits
per 1 kb of virus genome sequence for each group.
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Apart from investigating susceptibility to viral infections,
many other types of experiments can be proposed to
test this hypothesis. For example, the comparisons of
host and viral DNAs can be done in order to identify
homologous nucleotide motifs. It can be further investi-
gated (e.g., using Northern blot or microarray hybridiza-
tion) whether there are such motifs transcribed in the
antisense orientation relatively to viral gene transcrip-
tional direction. For those transcribed in the antisense
orientation relatively to viral gene expression, complete
host RNA primary structures can be established (e.g.,
using 5’-a n d3 ’ R A C Et e c h n i q u e[ 4 1 ] ) .T h e s eR N A s
may be assayed in functional tests whether they do
interfere with viral gene expression and progression of
ongoing infection using multiple in vitro and in vivo
approaches (e.g., by assessing the effects of overprodu-
cing RNAs of interest on viral infection or viral gene
expression).
Implications of the hypothesis
It is proposed here that non protein-coding parts of the
mammalian transcriptomes include thousands of
nucleotide motifs that can be employed to suppress viral
gene expression. We hypothesize that the evolutionary
success of some families of mammalian transposable ele-
ments may at least partly be due to their ability to pro-
vide substantial amounts of antiviral RNAs.
It could be also generalized that theoretically species
having increased genome sizes may resist various viral
Figure 4 Normalized content of the DNA motifs identical between the consensus sequences of human transposable elements and
human herpesviral and adenoviral DNAs. Bar heights are proportional to the relative content of perfectly matched BLAST hits per 1 kb of the
respective TE group consensus sequence. Human TE consensus sequences were taken from the database RepbaseUpdate [45].
Figure 5 Content of the mouse viral sequence motifs shared among the viral and mammalian DNAs. Murine adenovirus A and murid
herpesvirus 1 were screened against human and mouse genomic and EST databases. Bars delineate total numbers of 21-28 perfectly matched
BLAST hits for each category.
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Page 9 of 16infections stronger than related organisms with more
compact genomes. A practical implication probably
might be that introducing artificially engineered TE
sequences encoding antiviral RNAs could be advanta-
geous for creating strains and breeds of eukaryotic
organisms with the complex genomes that would be
more resistant against intracellular parasites, e.g. for the
needs of plant bioengineering. However, in this case
enlargements of genomic DNAs must be followed by
artificially accelerated mutation processes in order to
increase genome diversity and, therefore, to create addi-
tional structure motifs potentially interfering with viral
expression. The latter goal could be achieved using a
wide number of available physical or molecular methods
like gamma-irradiation and treatment with various
mutagenic chemicals [42,43]. Moreover, quick evolution
of the pathogenic viral genomes may be somewhat com-
pensated by the accumulation of mutations in multiple
TE copies which might significantly strengthen antiviral
response.
Conclusions
It is proposed that mammalian genomes contain thou-
sands of relatively short sequence motifs that may be
beneficial to the host organisms as a source of putative
interfering RNA molecules that can be recruited to
repress intracellular pathogens like viruses. We identi-
fied a large number of short sequences (21-29 bp long)
in human genome that are identical to sequences of dif-
ferent types of human adenoviruses and herpesviruses.
Many such motifs are transcribed and may be involved
in RNAi-mediated defense to viral infection. In this
case, RNAi could serve as an intracellular “immune sys-
tem” by repressing transcription of intra-genomic para-
sites like active viruses. We hypothesize here that that
the evolutionary success of some types of mammalian
genomic repeats and, in particular, of some TE families
may at least partly be due to their ability to provide sub-
stantial amounts of antiviral RNAs.
Reviewer’s comments
Reviewer’s report 1
Eugene V. Koonin (The National Center for Biotechnol-
ogy Information, NLM, NIH, Bethesda, USA)
Reviewer comments
Zabolotneva and Buzdin speculate that animal genomes
expand under selective pressure for generation of anti-
viral siRNAs. They illustrate the hypothesis by identify-
ing multiple 20-25 bp sequences identical to sequences
in adenovirus genome and also claim but do not show
similar findings for herpesvirus genomes.
I have major comments on both the conceptual and
technical levels. Conceptually, I am confident that the only
answer the question posed in the title of the paper is:
No, and the question itself makes little sense. Enlarge-
ment of the genome cannot be a mechanism at any rate
but, regardless of the semantics, to claim that it is an
adaptation, even in the general sense, let alone specifi-
cally for antiviral defense, is an obvious fallacy. To be
more specific, this idea assigns to the evolutionary the
kind of foresight it can never possess. There is no good
reason to question the population-genetic explanation of
the major increase in genome size seen in vertebrates,
namely, that the small effective population size of ani-
mals results in inefficient purifying selection and so pro-
vides fixation of even slightly deleterious features. The
genome growth is a manifestation of this fundamental
phenomenon and occurs by virtue of various processes
the most important of which are random DNA duplica-
tion and propagation of transposable elements. It is a
completely different matter than much (we currently do
not have a clear idea just how much) of the junk DNA
is co-opted for various functions including control of
selfish elements, both transposons and viruses, which is
indeed crucial.
The above is not an unqualified condemnation of this
manuscript in its entirety. In principle, it could be sal-
vaged by reformulating the hypothesis to “Are antiviral
small interfering RNAs encoded in animal genomes?”
When discussing this question, the authors should be
clear about the major known mechanism of generation
of antiviral siRNAs, namely, production from dsRNA
through the action of the RISC complex.
Author’s response
We agree. In the revised version, we re-formulated title
of the manuscript which is now as follows: “How many
antiviral small interfering RNAs may be encoded by the
mammalian genomes?”, and put numerous changes in
text to avoid conceptual problems mentioned by the
referee. Milestone references mentioned by Dr. Koonin
were added to the manuscript and discussed in the text.
Reviewer comments
However, not all viruses produce dsRNA, and in any
case, it would be quite interesting if animal genomes
indeed encoded siRNA against viruses, in addition to
known ones against transposable elements. In my view,
to substantiate such a hypothesis, several types of analy-
sis are necessary: (i) expand the analysis of virus-specific
sequences (at least, include the herpesvirus data but bet-
ter additional families of viruses), (ii) compare the
occurrence of virus-specific sequences to the random
expectation and calculate p-values, (iii) examine the
available transcriptome data for the presence of these
sequences in transcripts, (iv) investigate the distribution
of these sequences in the genome - are they found pri-
marily in introns or in intergenic regions or randomly?
If these results of such analysis point to functional rele-
vance, this could become a stimulating hypothesis.
Zabolotneva et al. Biology Direct 2010, 5:62
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We are extremely grateful for these advices by the
referee. In the revised version, we expand the analysis to
the additional 10 human herpesviral and 13 different
bacteriophagal genomes and statistically tested the data.
We also compare complementary motif occurrences in
viral DNA with four randomly generated 50 kb-long
“genomes”. Furthermore, we have analyzed distribution
of the EST hits among the different viral entries and
obtained the data that hopefully somewhat support our
hypothesis.
Reviewer’s comments on the revised version
Reviewer comments
In the revised version of their manuscript, Zabolotneva
and coworkers eliminated the major misconceptions of
their original manuscripta n da d d e ds o m ec o m p u t a -
tional analysis that aim at demonstrating the plausibility
of their idea that large mammalian genomes encode
numerous antiviral microRNAs. The removal of the “tel-
eological” aspects of the original article certainly makes
the new version more palatable, and an attempt to
incorporate more detailed sequence analysis is in itself
laudable. However, unfortunately, problems remain. The
bioinformatic analysis included in the paper is not pro-
fessional. The authors give no p-values for the excess of
t h ev i r u s - s p e c i f i cm o t i f st h a tt h e yd i s c o v e ra n dd on o t
explain the method the use to generate their random
sequences. Accordingly, all the analysis is out of context
and has no real meaning as there is no indication
whether or not the excess of hits in viral genomes com-
pared to random sequences and phages is statistically
significant or not.
Author’s response
In the present version of the paper, the excess of the
virus-specific motifs is shown to be statistically signifi-
cant. The calculated p-values are given in the separate
table (Table 1).
Reviewer comments
It would be advisable to calculate p-values both analyti-
cally and by comparison with random sequences that
would have to be generated by shuffling the actual viral
genomes (preferably, trying Markov models of different
orders). Under this approach, it is necessary to generate
many (at least, 1000, and preferably, more) random
sequences separately for each viral genome and deter-
mine where in the distribution of the number of hits is
the real genome. It also would be curious to reproduce
this procedure with bacteriophage genomes (very stran-
gely, in the current version, the authors do not specify
which page genomes they used).
Author’s response
In the new version, we specify adenoviral, herpesviral
and phage genomes in the tables 2 and 3.
As suggested by the referee, we compared human-virus
sequence identities using a panel of randomly generated
genomes. Using 2
nd -a n d5
th order Markov model we
generated random sequences by shuffling the actual ade-
noviral, herpesviral and bacteriophagal genomes. Under
this approach, 1000 random sequences were generated
separately for each investigated viral genome. We next
compared numbers of BLAST hits for the existing viral
genomes, and for in silico generated ones. The observed
BLAST hits (total numbers of BLAST hits were found for
each genome) were statistically analyzed (Table 2), and
the following was found: (i) the number of hits for the
existing adenoviral or herpesviral genome was mostly
higher than the 95
th percentile for a set of the corre-
sponding in silico-generated sequences (in 81% or 89% of
the cases, respectively, for 5
th order Markov model), (ii)
for the bacteriophages, this number was mostly below
t h e9 5 %p e r c e n t i l ea n de x p a n d e di to n l yi n3 8 %o ft h e
cases). Again, these data confirm that human-pathogenic
viruses share significantly greater structural identity with
the human genome than do the bacteriophagal genomes.
Importantly, this also implies that there was a kind of
positive selection for either the “virus-like” sequences in
the human DNA, or for the “humanized” DNA in the
human-pathogenic viruses, or both.
Reviewer comments
Beyond these technical issues, the article still involves
some conceptual vagueness. What is the authors’
hypothesis on the origin of the putative antiviral RNA?
Do they think that these sequences were acquired by
insertion of virus-specific DNA or have they just
emerged by chance? Both possibilities appear realistic,
and the choice of the best interpretation, to a large
extent, depends on the results of the statistical analysis
outlined above. Regardless, it is highly desirable to be
clear about the mechanistic aspects of the hypothesis.
Author’s response
In the new version, we state that: “there was a kind of
positive selection for either the “virus-like” sequences in
the human DNA, or for the “humanized” DNA in the
human-pathogenic viruses, or both.” At present, we can-
not be more certain about what flow in human-virus
DNA interchange is the most important.
Reviewer comments
The language of the manuscript remains quite poor. The
text might have been seen by a professional translator
who might have removed some of the errors but many
of these remain along with the overall poor style.
Author’s response
Native English-speaking colleague edited the text.
Reviewer’s report 2
Valerian V. Dolja (Department of Botany and Plant
Pathology, Oregon State University, Corvallis, USA)
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Virus type Genome size, kb Accession number
Human adenovirus type 1 36.001 [GenBank:AC_000017] [GenBank:BK005234]
Human adenovirus type 2 35.937 [GenBank:AC_000007]
Human adenovirus type 3, strain GB 35.345 [GenBank:NC_011203]
Human adenovirus type 4, strain NHRC 3 35.964 [GenBank:AY599837]
Human adenovirus type 5 35.938 [GenBank:AC_000008]
Human adenovirus type 7 35.514 [GenBank:AC_000018] [GenBank:BK005235]
Human adenovirus type 8 34.980 [GenBank:AB448769]
Human adenovirus type 9 35.083 [GenBank:NC_010956]
Human adenovirus type 11 34.794 [GenBank:AC_000015] [GenBank:BK001453]
Human adenovirus type 12 34.125 [GenBank:NC_001460]
Human adenovirus type 14 34.763 [GenBank:FJ822614]
Human adenovirus type 16 35.552 [GenBank:AY601636]
Human adenovirus type 17 35.100 [GenBank:AF108105]
Human adenovirus type 19 35.231 [GenBank:AB448774]
Human adenovirus type 22, isolate AV-2711 35.166 [GenBank:FJ404771]
Human adenovirus type 26 35.152 [GenBank:EF153474]
Human adenovirus type 28, strain BP-5 35.130 [GenBank:FJ824826]
Human adenovirus type 34, strain Compton 34.755 [GenBank:AY737797]
Human adenovirus type 35 34.794 [GenBank:AC_000019] [GenBank:BK005236]
Human adenovirus type 37 35.152 [GenBank:AB448778]
Human adenovirus type F 34.214 [GenBank:L19443]
Human adenovirus type 41, isolate TAK 34.188 [GenBank:DQ315364]
Human adenovirus type 46 35.178 [GenBank:AY875648]
Human adenovirus type 48 35.206 [GenBank:EF153473]
Human adenovirus type 49 35.215 [GenBank:DQ393829]
Human adenovirus type 50, strain Wan 35.385 [GenBank:AY737798]
Murine adenovirus A 30.944 [GenBank:NC_000942]
Human herpesvirus 1 152.261 [GenBank:NC_001806]
Human herpesvirus 2 154.746 [GenBank:NC_001798]
Human herpesvirus 3 124.884 [GenBank:NC_001348]
Human herpesvirus 4 171.823 [GenBank:NC_007605]
Human herpesvirus 4, type 2 172.764 [GenBank:NC_009334]
Human herpesvirus 5 235.646 [GenBank:NC_009334]
Human herpesvirus 6 159.322 [GenBank:NC_009334]
Human herpesvirus 6, type 2 162.114 [GenBank:NC_000898]
Human herpesvirus 7 153.080 [GenBank:NC_001716]
Human herpesvirus 8 137.969 [GenBank:NC_009333]
Murid herpesvirus 1 230.278 [GenBank:NC_004065]
Microcystis phage MA-LMM01 169.109 [GenBank:NC_008562]
Bacillus phage 0305 phi 8-36 218.948 [GenBank:NC_009760]
Pseudomonas phage DMS 3 36.415 [GenBank:NC_008717]
Enterobacteria phage HK022 40.751 [GenBank:NC_002166]
Enterobacteria phage lambda 48.502 [GenBank:NC_001416]
Mycobacterium phage Cali 155.372 [GenBank:NC_011271]
Pseudomonas phage SN 66.390 [GenBank:NC_011756]
Rhizobium phage 16-3 60.195 [GenBank:NC_011103]
Burkholderia phage BcepNY3 47.382 [GenBank:NC_009604]
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Page 12 of 16Reviewer comments
This Hypothesis article by Anastasia Zabolotneva and
Anton Buzdin advances a concept according to which
the eukaryotes with large (e.g., polyploid) genomes take
a d v a n t a g eo fal a r g es u p p l yo f genetic material that is
not a subject of purifying selection to evolve antiviral
RNA transcripts. It is further proposed that such tran-
scripts could activate RNAi machinery and therefore
suppress the infection.
This concept is well in line with the recent striking
findings of the bacterial anti-phage CRISPR defense sys-
tem and growing number of instances of acquisition of
RNA virus sequences by eukaryotic genomes that were
also proposed to function in antiviral defense (see a suc-
cinct commentary by Eugene Koonin, 2010). Although a
welcome generalization, current Hypothesis appears to
be rather thin on supporting evidence and lacking in
specifics as it comes to the involved molecular mechan-
isms. Below is a laundry list of comments addressing
which could, in my opinion, strengthen the case made
by the authors.
1. The only bioinformatics support for the hypothesis
comes from finding a substantial number of short
sequences identical to human adenoviruses in the
human genome. It is not clear, however, if there is any
positive selection/enrichment for such sequences or, if
their occurrence is purely incidental. It seems that a
simple in silico experiment could provide an important
insight into this issue. If the genomes of DNA phages
similar in size to adenoviruses are used as a query, will
there be a similar or significantly lower number of
hits? Since phages do not infect humans, the latter
outcome would be supportive of positive selection for
the retention of human virus related sequences rather
than for mere stochastic occurrence of the irrelevant
sequences.
Author’s response
In the revised version - done exactly as suggested by the
referee (see also our reply #2 to the reviewer 1).
Reviewer comments
2. Along the similar lines, it is not specified if there are
any pathways in addition to positive selection (that in
itself could be insufficient) that allows for selective
retention of antiviral sequences as opposed to those
affecting human own genes. Again, a simple search for,
e.g., sequences identical to ribosomal RNAs (outside the
rRNA genes proper) could provide relevant insight.
Author’s response
We omitted this type of analysis suggested by the
referee because mammalian genomes (and human gen-
ome as well) contain huge numbers of pseudogenes for
rRNA that significantly bias interpretation of the data.
Reviewer comments
3. Proposed hypothesis testing via comparing viral sus-
ceptibility of the closely related organisms with con-
trasting genome size appears to be conceptually
problematic. The case in point is plant species that
underwent evolutionary recent polyploidy transitions.
Such plants tend to be more rapidly growing and vig-
orous than their diploid kin. Consequently, if the for-
mer are found to be more virus-resistant than the
latter, it could be attributed to their overall vigor (and/
or increased complement of innate and acquired
immunity genes) rather than to acquisition of addi-
tional antiviral sequences.
Author’s response
We agree. The paper has been seriously revised and the
confusing part was removed from the manuscript.
Reviewer comments
4. It is not clear why the RNAi-based antiviral response
invoked in the paper is habitually called ‘intercellular’
immune system. Even though cell-to-cell and long-dis-
tance spread of RNAi signaling is described for plants
and C. elegans, by and large, the RNAi machinery is
cell-autonomous, that is, is expressed in each cell.
Author’s response
Corrected through the manuscript.
Reviewer comments
The paper needs to be heavily edited against numerous
typos (e.g. ‘specie’ throughout the text), as well as gram-
matical and stylistic errors (e.g., ‘Theoretically, a practi-
cal implication could be...’, on p. 8; an oxymoron).
Author’s response
A professional interpreter edited the revised version.
Table 3 List of viral genomes under investigation (Continued)
Klebsiella phage KP32 41.119 [GenBank:NC_013647]
Pseudomonas phage phi-2 43.144 [GenBank:NC_013638]
Halomonas phage phiHAP-1 39.245 [GenBank:NC_010342]
Xylella phage Xfas53 36.674 [GenBank:NC_013599]
Randomly generated genome 1 50.000 -
Randomly generated genome 2 50.000 -
Randomly generated genome 3 50.000 -
Randomly generated genome 4 50.000 -
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Yuri V. Shpakovski (Shemyakin-Ovchinnikov Institute of
Bioorganic Chemistry, Russian Academy of Sciences,
Moscow, Russia)
Reviewer comments
I was hesitant to review the original version of the
manuscript because the general idea of the paper in its
original form (Zabolotneva A. & Buzdin A.: Hypothesis:
may enlargement of eukaryotic genome size be a
mechanism of anti-viral host cell defense?) was really
misleading - in my opinion the case presented have
merely nothing to do with the enlargement of eukaryotic
genomes and with the so-called C-value or G-value
paradoxes. Unfortunately, the remnants of this miscon-
ception are still in the paper’s text (e.g. the idea of creat-
ing “polyploid eukaryotic organisms that would be more
resistant against intracellular parasites ... for the needs
of plant bioengineering”), and without this strange ‘gen-
o m es i z ea s s o c i a t i o n ’ (which I believe to be wrong) the
so-called hypothesis presented in the manuscript ("We
propose a hypothesis that eukaryotic genomes encode
short RNA motifs that may serve for the antiviral pro-
tection...”) does not have so much actual novelty.
Indeed, a very nice review of Gottwein E. & Cullen B.
R. “Viral and cellular microRNAs as determinants of
viral pathogenesis and immunity” (published in Cell
Host Microbe, 2008, Vol. 3, No. 6, pp. 375-387) not
only contains more wide, stimulating and scientifically
grounded discussion of the involvement of RNAi
mechanisms in virus-host interactions, but even offers
some experimentally verified examples of the impact of
host miRNAs on viral replication and pathogenesis.
Authors of the new submission must clearly and
unequivocally specify what real novelty their hypothesis
contains: the general answer on the question posted in a
new title (Are antiviral small interfering RNAs encoded
in EUKARYOTIC genomes?) after such for some reason
omitted in the paper’s Reference list publications as
Lecellier et al. (Science, 2005, 308: 557-560), Otsuka et
al. (Immunity, 2007, 27: 123-134), Pedersen et al. (Nat-
ure, 2007, 449: 919-922), Ahluwalia et al. (Retrovirology,
2008, 5:117) is obvious YES. All these publications show
that some cellular miRNAs play a role in direct or indir-
ect regulation of viral genes. These small interfering
RNAs are broadly implicated in viral infection of mam-
malian cells, with either positive or negative effects on
viruses’ replication. And I am talking here only about
mammalian species, because the involvement of RNAi
in the innate antiviral immune response in plants and
invertebrate animals is already well documented.
Author’s response
We are very thankful to the referee for his valuable criti-
cism. Indeed, the initial version of the manuscript was
greatly overlapping with the abovementioned papers. In
the present version, an attempt has been made to avoid
ambiguous sentences, e.g. concerning polyploid organ-
isms. As to the novelty, to meet the referee suggestion
we revised the major concept of the manuscript. We
propose a hypothesis that mammalian DNAs and, in
particular, human genome, encode thousands of the
RNA motifs that may serve for the antiviral protection.
We also presume that the evolutional success of some
groups of genomic repeats and, in particular, transposa-
ble elements (TEs) may be due to their ability to provide
to the host organism antiviral RNA motifs. Genomic
repeat intense propagation into the genome inevitably
causes bidirectional transcription of these sequences,
and the resulting double-stranded RNAs may be recog-
nized and processed by the RNA interference enzymatic
machinery. Provided that these processed target motifs
may be complementary to viral transcripts, fixation of
the repeats into the genome may be of a considerable
benefit to the host.
Reviewer comments
I also have some comments concerning the computa-
tional data presented in a new manuscript’s submission.
The comparison of the occurrence of virus-specific
sequences to the random expectation or to bacteriopha-
gal sequences has a very limited scientific value (if any)
- of course, the genomes interacting in the course of
e v o l u t i o nh a v em o r ei nc o m m o nt h a ne v o l u t i o n a r i l y
unrelated or artificially chosen sequences. More relevant
to the case presented could be testing by bioinformatics
means the virus-host specificity of the discussed short
RNA motifs present in different mammalian species:
was there any co-evolution of the viral and host-
acquired sequences or not?.. The positive correlation
could probably strengthen the case. Particularly, this
kind of viral-host sequence comparison could be done
using as queries genomes of the viruses for which is
already known that they are using RNAi machinery in
their interaction with the hosts: human and mouse cyto-
megaloviruses (hCMV and mCMV), human, simian and
murine rhadinoviruses (KSHV, RRV, MHV68), human
and rhesus lymphocryptoviruses (EBV & rLCV).
Author’s response
We added the results of some additional bioinformatical
tests to the present version. We extracted from genomic
databases the available mouse adenovirus and herpes-
virus genomes (Murine adenovirus A and Murid herpes-
virus 1) and screened them against human and mouse
genomic and EST databases. For both mouse adenoviral
and herpesviral genomes, the number of 21-28 nt-long
hits was higher when searched through the mouse geno-
mic and EST databases compared to the human data-
bases. Among the identified virus-like hits presented in
both human and mouse DNAs, three sequences were
simple repeats represented by multiple copies in both
Zabolotneva et al. Biology Direct 2010, 5:62
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GATG, CATCCATCCATCCATCCATCC and ATTCTT
TCATTCTTTCATTCTTT). Importantly, their copy
numbers were very different in the mouse and human
DNAs (mouse/human): 1216/194, 20384/13893 and
1120/192, respectively. Thus, a kind of positive selection
for simple repetitive elements matching genomes of the
viruses with the respective tropism may theoretically
take place in this case. Overall, these data are supportive
towards the general concept of this manuscript. We
have also tested the presence of adeno- and herpesvirus-
like motifs in the consensus sequences of human trans-
posable elements and found that abundant genomic Alu
repeats are enriched in such elements. We thank the
referee for recommending a strategy of further studies
that would include subsequent comparisons of various
herpesviral genomes with the DNAs of their hosts and
vice versa. However, these studies go beyond the scope
of this hypothesis paper and will be a matter of our
further research projects that would include also a
detailed analysis of coevolution of genomic repeats,
viruses and their hosts for various mammalian
organisms.
Abbreviations
RNAi: RNA interference; siRNA: small interfering RNA(s); dsRNA: double
stranded RNA(s); TE: transposable elements; RACE: rapid amplification of
cDNA ends.
Acknowledgements
The authors thank the referees for their valuable comments and constructive
criticism. This authors were supported by the “Molecular and cellular
biology” grant from the Presidium of Russian Academy of Sciences, by the
President of Russian Federation grant MD-2010 and by the Russian
Foundation for Basic Research grants 10-04-00593 and 09-04-12302.
Author details
1Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy
of Sciences, 16/10 Miklukho-Maklaya st, Moscow 117997, Russia.
2Deutsche
Bank Russia, Sadovnicheskaya 82 building 2, Moscow 117312, Russia.
3Hematology Research Center, Russian Academy of medical sciences, 4a
Novy Zykovsky Pr., Moscow 125167, Russia.
Authors’ contributions
AZ participated in the sequence alignment, in the recovery of the identical
motifs between the mammalian and viral genomes, and took part in writing
the paper. VT did the major part of sequence alignment and statistic
analyses. FF participated in the hypothesis presentation and in writing the
paper. AB formulated the hypothesis, conceived of the study, and
participated in its design and coordination, and drafted the manuscript. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 20 October 2010 Accepted: 8 November 2010
Published: 8 November 2010
References
1. Hannon GJ, Rossi JJ: Unlocking the potential of the human genome with
RNA interference. Nature 2004, 431:371-378.
2. Meister G, Tuschl T: Mechanisms of gene silencing by double-stranded
RNA. Nature 2004, 431:343-349.
3. Aravin AA, Sachidanandam R, Bourc’his D, Schaefer C, Pezic D, Toth KF,
Bestor T, Hannon GJ: A piRNA pathway primed by individual transposons
is linked to de novo DNA methylation in mice. Mol Cell 2008, 31:785-799.
4. Li LC, Okino ST, Zhao H, Pookot D, Place RF, Urakami S, Enokida H,
Dahiya R: Small dsRNAs induce transcriptional activation in human cells.
Proc Natl Acad Sci USA 2006, 103:17337-17342.
5. Mello CC, Conte D Jr: Revealing the world of RNA interference. Nature
2004, 431:338-342.
6. Kutter C, Svoboda P: miRNA, siRNA, piRNA: Knowns of the unknown. RNA
Biol 2008, 5:181-188.
7. Tang G: siRNA and miRNA: an insight into RISCs. Trends Biochem Sci 2005,
30:106-114.
8. Ambros V: The functions of animal microRNAs. Nature 2004, 431:350-355.
9. Carrington JC, Ambros V: Role of microRNAs in plant and animal
development. Science 2003, 301:336-338.
10. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K,
Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A,
Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K,
Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M,
Santos R, Sheridan A, Sougnez C, et al: Initial sequencing and analysis of
the human genome. Nature 2001, 409:860-921.
11. Wessler SR: Transposable elements and the evolution of eukaryotic
genomes. Proc Natl Acad Sci USA 2006, 103:17600-17601.
12. Belancio VP, Hedges DJ, Deininger P: Mammalian non-LTR
retrotransposons: for better or worse, in sickness and in health. Genome
Res 2008, 18:343-358.
13. Brennecke J, Malone CD, Aravin AA, Sachidanandam R, Stark A, Hannon GJ:
An epigenetic role for maternally inherited piRNAs in transposon
silencing. Science 2008, 322:1387-1392.
14. Evgen’ev MB, Arkhipova IR: Penelope-like elements–a new class of
retroelements: distribution, function and possible evolutionary
significance. Cytogenet Genome Res 2005, 110:510-521.
15. Gogvadze E, Buzdin A: Retroelements and their impact on genome
evolution and functioning. Cell Mol Life Sci 2009, 66:3727-3742.
16. Zakharenko L, Perepelkina M: The possible effect of transposons on the
Drosophila melanogaster somatic mutation and recombination test.
Mutat Res 2009, 670:1-5.
17. Aravin AA, Naumova NM, Tulin AV, Vagin VV, Rozovsky YM, Gvozdev VA:
Double-stranded RNA-mediated silencing of genomic tandem repeats
and transposable elements in the D. melanogaster germline. Curr Biol
2001, 11:1017-1027.
18. Tabara H, Sarkissian M, Kelly WG, Fleenor J, Grishok A, Timmons L, Fire A,
Mello CC: The rde-1 gene, RNA interference, and transposon silencing in
C. elegans. Cell 1999, 99:123-132.
19. Busseau I, Chaboissier MC, Pelisson A, Bucheton A: I factors in Drosophila
melanogaster: transposition under control. Genetica 1994, 93:101-116.
20. Dramard X, Heidmann T, Jensen S: Natural epigenetic protection against
the I-factor, a Drosophila LINE retrotransposon, by remnants of ancestral
invasions. PLoS One 2007, 2:e304.
21. Klenov MS, Lavrov SA, Stolyarenko AD, Ryazansky SS, Aravin AA, Tuschl T,
Gvozdev VA: Repeat-associated siRNAs cause chromatin silencing of
retrotransposons in the Drosophila melanogaster germline. Nucleic Acids
Res 2007, 35:5430-5438.
22. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S,
Romero DA, Horvath P: CRISPR provides acquired resistance against
viruses in prokaryotes. Science 2007, 315:1709-1712.
23. Flegel TW: Hypothesis for heritable, anti-viral immunity in crustaceans
and insects. Biol Direct 2009, 4:32.
24. Koonin EV: Taming of the shrewd: novel eukaryotic genes from RNA
viruses. BMC Biol 8:2.
25. Haasnoot J, Westerhout EM, Berkhout B: RNA interference against viruses:
strike and counterstrike. Nat Biotechnol 2007, 25:1435-1443.
26. Aliyari R, Ding SW: RNA-based viral immunity initiated by the Dicer family
of host immune receptors. Immunol Rev 2009, 227:176-188.
27. Gottwein E, Cullen BR: Viral and cellular microRNAs as determinants of
viral pathogenesis and immunity. Cell Host Microbe 2008, 3:375-387.
28. Ahluwalia JK, Khan SZ, Soni K, Rawat P, Gupta A, Hariharan M, Scaria V,
Lalwani M, Pillai B, Mitra D, Brahmachari SK: Human cellular microRNA hsa-
Zabolotneva et al. Biology Direct 2010, 5:62
http://www.biology-direct.com/content/5/1/62
Page 15 of 16miR-29a interferes with viral nef protein expression and HIV-1
replication. Retrovirology 2008, 5:117.
29. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C,
Saib A, Voinnet O: A cellular microRNA mediates antiviral defense in
human cells. Science 2005, 308:557-560.
30. Otsuka M, Jing Q, Georgel P, New L, Chen J, Mols J, Kang YJ, Jiang Z, Du X,
Cook R, Das SC, Pattnaik AK, Beutler B, Han J: Hypersusceptibility to
vesicular stomatitis virus infection in Dicer1-deficient mice is due to
impaired miR24 and miR93 expression. Immunity 2007, 27:123-134.
31. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M:
Interferon modulation of cellular microRNAs as an antiviral mechanism.
Nature 2007, 449:919-922.
32. Zeyl C: Budding yeast as a model organism for population genetics.
Yeast 2000, 16:773-784.
33. Parfrey LW, Lahr DJ, Katz LA: The dynamic nature of eukaryotic genomes.
Mol Biol Evol 2008, 25:787-794.
34. Koonin EV: Darwinian evolution in the light of genomics. Nucleic Acids Res
2009, 37:1011-1034.
35. Lynch M: The frailty of adaptive hypotheses for the origins of organismal
complexity. Proc Natl Acad Sci USA 2007, 104(Suppl 1):8597-8604.
36. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R,
Ravasi T, Lenhard B, Wells C, Kodzius R, Shimokawa K, Bajic VB, Brenner SE,
Batalov S, Forrest AR, Zavolan M, Davis MJ, Wilming LG, Aidinis V, Allen JE,
Ambesi-Impiombato A, Apweiler R, Aturaliya RN, Bailey TL, Bansal M,
Baxter L, Beisel KW, Bersano T, Bono H, et al: The transcriptional landscape
of the mammalian genome. Science 2005, 309:1559-1563.
37. Kapranov P, Willingham AT, Gingeras TR: Genome-wide transcription and
the implications for genomic organization. Nat Rev Genet 2007, 8:413-423.
38. Patrushev LI, Minkevich IG: The problem of the eukaryotic genome size.
Biochemistry (Mosc) 2008, 73:1519-1552.
39. Goncalves MA, de Vries AA: Adenovirus: from foe to friend. Rev Med Virol
2006, 16:167-186.
40. Chang DY, Hsu K, Maraia RJ: Monomeric scAlu and nascent dimeric Alu
RNAs induced by adenovirus are assembled into SRP9/14-containing
RNPs in HeLa cells. Nucleic Acids Res 1996, 24:4165-4170.
41. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR,
Vogelstein B, Kinzler KW: Gene expression profiles in normal and cancer
cells. Science 1997, 276:1268-1272.
42. Singer B: DNA damage: chemistry, repair, and mutagenic potential. Regul
Toxicol Pharmacol 1996, 23:2-13.
43. Watanabe T, Tanaka G, Hamada S, Namiki C, Suzuki T, Nakajima M,
Furihata C: Dose-dependent alterations in gene expression in mouse
liver induced by diethylnitrosamine and ethylnitrosourea and
determined by quantitative real-time PCR. Mutat Res 2009, 673:9-20.
44. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment
search tool. J Mol Biol 1990, 215:403-410.
45. Jurka J, Kapitonov VV, Pavlicek A, Klonowski P, Kohany O, Walichiewicz J:
Repbase Update, a database of eukaryotic repetitive elements. Cytogenet
Genome Res 2005, 110:462-467.
doi:10.1186/1745-6150-5-62
Cite this article as: Zabolotneva et al.: How many antiviral small
interfering RNAs may be encoded by the mammalian genomes? Biology
Direct 2010 5:62.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Zabolotneva et al. Biology Direct 2010, 5:62
http://www.biology-direct.com/content/5/1/62
Page 16 of 16